Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.
Frequently asked questions
What sector does Igene Biotechnology Inc (IGNE) operate in?
Igene Biotechnology Inc belongs to the Materials sector and operates in the Agricultural Inputs industry.
What is Igene Biotechnology Inc (IGNE) current stock price?
As of the latest data, Igene Biotechnology Inc stock price is $0.00, with a previous close of $0.00. Igene Biotechnology Inc gained $0.00 in the last trading session, representing a 900% increase.
What is Igene Biotechnology Inc (IGNE) current market capitalization?
Igene Biotechnology Inc market cap is approximately 156.54 thousand.
Does Igene Biotechnology Inc (IGNE) pay dividends?
No. Igene Biotechnology Inc does not pay a dividend.
What is Igene Biotechnology Inc (IGNE) beta (volatility) score?
Igene Biotechnology Inc has a beta of -30.754, indicating lower volatility than the overall market.